Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
Hong Kong · Delayed Price · Currency is HKD 8.83
+0.14 (1.55%)
Aug 21, 2026, 4:08 PM HKT
HKG:1858 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,691 | 8,722 | 4,729 | 9,542 | 9,282 | 11,148 | |
Market Cap Growth | -34.65% | 84.43% | -50.44% | 2.80% | -16.74% | 47.19% |
Enterprise Value | 3,296 | 6,544 | 2,606 | 7,832 | 7,563 | 10,429 |
Last Close Price | 8.82 | 14.59 | 8.23 | 11.32 | 14.18 | 13.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.78 | 28.76 | 35.56 | 31.18 | 26.68 | 28.17 |
Forward PE | 8.50 | 19.82 | 10.02 | 12.89 | 14.67 | 11.29 |
PS Ratio | 4.85 | 7.50 | 5.52 | 7.17 | 6.83 | 8.20 |
PB Ratio | 1.64 | 2.62 | 1.58 | 3.01 | 3.02 | 3.68 |
P/TBV Ratio | 1.71 | 2.74 | 1.65 | 3.18 | 3.18 | 3.89 |
P/FCF Ratio | 12.26 | 22.67 | - | 18.10 | 509.88 | - |
P/OCF Ratio | 10.67 | 19.36 | - | 16.93 | 200.22 | 55.12 |
PEG Ratio | - | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.81 | 5.62 | 3.04 | 5.88 | 5.57 | 7.67 |
EV/EBITDA Ratio | 9.00 | 19.00 | 19.01 | 24.14 | 21.62 | 23.54 |
EV/EBIT Ratio | 10.35 | 21.76 | 26.63 | 27.21 | 23.78 | 24.67 |
EV/FCF Ratio | 7.10 | 17.01 | - | 14.86 | 415.45 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0.00 | 0 | 0 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Debt / FCF Ratio | 0.01 | 0.01 | - | 0.00 | 0.08 | - |
Net Debt / Equity Ratio | -0.69 | -0.74 | -0.67 | -0.73 | -0.63 | -0.70 |
Net Debt / EBITDA Ratio | -6.59 | -7.16 | -14.63 | -7.12 | -5.57 | -4.81 |
Net Debt / FCF Ratio | -5.16 | -6.41 | 36.90 | -4.38 | -107.04 | 50.12 |
Asset Turnover | 0.29 | 0.29 | 0.23 | 0.34 | 0.38 | 0.49 |
Inventory Turnover | 0.70 | 0.72 | 0.59 | 1.02 | 1.44 | 1.61 |
Quick Ratio | 4.92 | 4.26 | 4.17 | 3.78 | 4.21 | 5.16 |
Current Ratio | 6.09 | 5.21 | 5.20 | 4.44 | 4.66 | 5.57 |
Return on Equity (ROE) | 9.32% | 9.39% | 4.37% | 9.92% | 11.86% | 18.17% |
Return on Assets (ROA) | 4.93% | 4.74% | 1.62% | 4.63% | 5.49% | 9.48% |
Return on Invested Capital (ROIC) | 29.66% | 28.62% | 10.13% | 26.68% | 29.71% | 53.72% |
Return on Capital Employed (ROCE) | 8.90% | 8.80% | 3.20% | 8.80% | 10.00% | 13.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.52% | 3.48% | 2.81% | 3.21% | 3.75% | 3.55% |
FCF Yield | 8.16% | 4.41% | -1.15% | 5.52% | 0.20% | -0.38% |
Dividend Yield | 4.84% | 2.74% | 1.71% | 3.52% | 2.50% | 1.21% |
Payout Ratio | 35.84% | 6.87% | 136.44% | 43.21% | 16.23% | - |
Buyback Yield / Dilution | -1.73% | -1.35% | 1.84% | -0.32% | -10.97% | -0.30% |
Total Shareholder Return | 3.10% | 1.40% | 3.55% | 3.21% | -8.48% | 0.90% |